Abstract
Summary
We examined fragility fracture patients’ perceptions of associations between bone health and other chronic conditions and medications. Awareness of the associations between bone health and these conditions and medications was low. Providers should increase patients’ awareness of these associations in order to minimize the risk of future fracture.
Introduction
Among patients with a fragility fracture presenting with at least one other chronic health condition, we examined (1) perceptions of the association between bone health and their other health conditions, and (2) perceptions of the association between bone health and prescribed medications taken for other health conditions.
Methods
We identified fragility fracture patients presenting to a Canadian urban fracture clinic with at least one self-reported chronic health condition (in addition to bone fragility). In-depth interviews, 60–90 min in duration, were conducted. Our qualitative methodology was informed by saliency analysis.
Results
We interviewed 26 patients (21 females, 5 males) aged 45 to 84 years old. Participants were taking 1–13 medications each and presented with a variety of comorbidities (range 1–7). All participants described at least one condition or medication they were currently taking for which there existed evidence of a negative effect on bone health (increased risk of fracture, bone loss, falling). Two participants perceived a correct association between their other health conditions and compromised bone health, and four participants perceived a correct association between their medications and compromised bone health.
Conclusion
All patients reported a chronic health condition and/or were taking at least one medication that potentially compromised their bone health. Patient awareness of the association between bone health and other health conditions and prescribed medications was low. Health care providers should increase patients’ awareness of the bone health significance of their chronic conditions and medications in order to minimize the risk of future fracture.
Similar content being viewed by others
References
Morrish DW, Beaupre LA, Bell NR, Cinats JG, Hanley DA, Harley CH, Juby AG, Lier DA, Maksymowych WP, Majumdar SR (2009) Facilitated bone mineral density testing versus hospital-based case management to improve osteoporosis treatment for hip fracture patients: additional results from a randomized trial. Arthritis Rheum 61(2):209–215
Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, Maksymowych WP, Steiner IP, Harley CH, Wirzba BJ, Hanley DA, Blitz S, Russell AS (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141(5):366–373
Ho C, Cranney A, Campbell A (2006) Measuring the impact of pharmacist intervention: results of patient education about osteoporosis after fragility fracture. Canadian Journal of Hospital Pharmacy 59(4):184–193
Hafez EA, Mansour HE, Hamza SH, Moftah SG, Younes TB, Ismail MA (2011) Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clinical Medical Insights: Arthritis and Musculoskeletal Disorders 2011(4):87–94
Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int 79:84–94
Wu Q, Liu B, Tonmoy S (2018) Depression and risk of fractures and bone loss: an updated meta-analysis of prospective studies. Osteoporos Int 29(6):1303–1312
Briot K, Geusens P, Em Bultink I, Lems WF, Roux C. Inflammatory diseases and bone fragility. Osteoporosis International 2017;28(12):3301-14
Bolton JM, Morin SN, Majumdar SER, al. e. Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiatry 2017;74(6):641–648
Lee RH, Lyles KW, Colon-Emeric C (2010) A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 8(1):34–46
Kahlaee HR, Latt MD, Schneider CR (2018) Association between chronic or acute use of antihypertensive class of medications and falls in older adults. A systematic review and meta-analysis. Am J Hypertens 31(4):467–479
Vranken L, Wyers CE, Van der Velde RY et al (2018) Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service. Osteoporos Int 29:397–407
Munson JC, Bynum JPW, Bell J-E, Cantu R, McDonough C, Wang Q, Tosteson TD, Tosteson AN (2016) Patterns of prescription drug use before and after fragility fracture. JAMA Intern Med 176(10):1531–1538
Litwic AE, Compston JE, Wyman A et al (2018) Self-perception of fracture risk: what can it tell us? Osteoporos Int 28(12):3495–3500
Sale JEM, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22(7):2067–2082
Ganda K, Puech M, Chen JS, Speerin R, Bleasel J, Center JR, Eisman JA, March L, Seibel MJ (2013) Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int 24:393–406
Sandelowski M (2000) Whatever happened to qualitative description? Res Nurs Health 23:334–340
Sandelowski M (2010) What’s in a name? Qualitative description revisited. Res Nurs Health 33:77–84
Bogoch ER, Elliot-Gibson F, Beaton D, Sale J, Josse R (2017) Fracture prevention in the orthopaedic environment: outcomes of a coordinator-based fracture liaison service. J Bone Joint Surg 99:820–831
Bogoch ER, Elliot-Gibson V, Wang RYC, Josse GJ (2012) Secondary causes of osteoporosis in fracture patients. J Orthop Trauma 26(9):e145–ee52
Langdridge D. Phenomenological psychology: theory, research and method. Harlow, England: Pearson Prentice Hall, 2007
Davis JC, Guy P, Ashe MC, Liu-Ambrose T, Khan K (2007) HipWatch: osteoporosis investigation and treatment after a hip fracture: a 6-month randomized controlled trial. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 62(8):888–891
Bajcar JM, Wang L, Moineddin R, Nie JX, Tracy CS, Upshur REG (2010) From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997–2006. BMC Fam Pract 11:75–1–75-6
Canada S. A portrait of seniors in Canada. Ottawa, ON, 2006:1–301
Arden NK, Nevitt MC, Lane NE, Gore LR, Hochberg MC, Scott JC, Pressman AR, Cummings SR (1999) Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Arthritis Rheum 42(7):1378–1385
NIH Osteoporosis and Related Bone Diseases National Resource Center (2018) What people with asthma need to know about osteoporosis. Bethesda, MD
Kvale S (1996) Interviews: an introduction to qualitative research interviewing. Sage Publications, Thousand Oaks, CA
Crabtree BF, Miller WL (1992) Doing qualitative research. Sage Publications, Newbury Park, CA
Buetow S (2010) Thematic analysis and its reconceptualization as ‘saliency analysis’. Journal of Health Services Research & Policy 15(2):123–125
Sandelowski M (2001) Real qualitative researchers do not count: the use of numbers in qualitative research. Res Nurs Health 24:230–240
Dixon-Woods M, Shaw RL, Agarwal S, Smith JA (2004) The problem of appraising qualitative research. Quality and Safety in Health Care 13:223–225
Kvale S, Brinkmann S (2009) Interviews: learning the craft of qualitative research interviewing, 2nd edn. Sage Publications Ltd., Thousand Oaks
Sandelowski M (1995) Sample size in qualitative research. Res Nurs Health 18:179–183
Shah VN, Shah CS, Snell-Bergeon JK (2015) Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med 32:1134–1142
Ferrari SL, Abrahamsen B, Napoli N, Akesson K, Chandran M, Eastell R, el-Hajj Fuleihan G, Josse R, Kendler DL, Kraenzlin M, Suzuki A, Pierroz DD, Schwartz AV, Leslie WD, Bone and Diabetes Working Group of IOF (2018) Diagnosis and management of bone fragility in diabetes: an emerging challenge. Osteoporos Int 29(12):2585–2596
Vestergaard P (2005) Epilepsy, osteoporosis and fracture risk—a meta-analysis. Acta Neurol Scand 112(5):277–286
McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT (2010) Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 51(8):937–946
Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR (2013) Low bone density in systemic sclerosis. A systematic review. J Rheumatol 40(1):1881–1890
Eimar H, Saltaji H, Ghorashi S et al (2017) Association between sleep apnea and low bone mass in adults: a systematic review and meta-analysis. Osteoporos Int 28:1835–1852
Huang AR, Mallet L, Rochefort CM, Equale T, Buckeridge DL, Tamblyn R (2012) Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 29(5):359–376
Nguyen KD, Bagheri B, Bagheri H (2018) Drug-induced bone loss: a major safety concern in Europe. Expert Opin Drug Saf 17(10):1005–1014
American Geriatrics Society 2019 Beers Criteria Update Expert Panel (2019) American Geriatrics Society 2019 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67(4):647–694
Hegeman JH, van den Bemt BJF, Duysens J, van Limbeek J (2009) NSAIDS and the risk of accidental falls in the elderly: a systematic review. Drug Saf 32(6):489–498
Rucker D, Rowe BH, Johnson JA, Steiner IP, Russell AS, Hanley DA, Maksymowych WP, Holroyd BR, Harley CH, Morrish DW, Wirzba BJ, Majumdar SR (2006) Educational intervention to reduce falls and fear of falling in patients after fragility fracture: results of a controlled pilot study. Prev Med 42(4):316–319
Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623–2637
Cristancho P, Lenze EJ, Avidan MS, Rawson KS (2016) Trajectories of depressive symptoms after hip fracture. Psychol Med 46(7):1413–1425
Zia A, Kamaruzzaman SB, Tan MP (2015) Polypharmacy and falls in older people: balancing evidence-based medicine against falls risk. Postgrad Med 127(3):330–337
Dahodwala M, Geransar R, Babion J, de Grood J, Sargious P (2018) The impact of the use of video-based educational interventions on patient outcomes in hospital settings: a scoping review. Patient Educ Couns 101:2116
Abed MA, Himmel W, Vormfelde S, Koschack J (2014) Video-assisted patient education to modify behavior: a systematic review. Patient Educ Couns 97:16–22
Khan MN, Khan AA (2008) Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol 15(Supplement 1):S30–S40
Mazziotti G, Canalis E, Giustina A (2010) Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med 123:877–884
Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S, Visalli E, Bagnato G (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 8(6):e66991
Acknowledgments
Funding for this project was provided by the Canadian Institutes of Health Research (MOP – 136934). Joanna Sale held a Canadian Institutes of Health Research New Investigator Salary Award (Funding Reference Number COB-136622) at the time the manuscript was submitted.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sale, J., Frankel, L., Bogoch, E. et al. Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications. Osteoporos Int 31, 2047–2055 (2020). https://doi.org/10.1007/s00198-020-05409-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-020-05409-w